<DOC>
	<DOC>NCT00707603</DOC>
	<brief_summary>Chronic hepatitis C (CHC) is among the commonest chronic infectious disease in Australia with &gt;200,000 exposed persons. Amongst non-infectious chronic conditions- Type 2 diabetes, obesity and heart disease are extremely common. This study will examine the relationship between insulin resistance, fat deposition in the liver, muscle and abdomen, and liver injury due to CHC</brief_summary>
	<brief_title>Chronic Hepatitis C and Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Caucasian male Age: 2555 years Chronic Hepatitis C (PCR positive) and fibrosis â‰¤ F2 (if liver biopsy done) Genotypes 1 or 3 Due to commence antiviral therapy BMI &lt; 30 Cirrhosis or F3 fibrosis on liver biopsy (if done) &gt; 20 g ETOH per day Type 2 Diabetes (need an OGTT if fasting BGL&gt; 5.7) Concurrent HIV Other cause of liver disease</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Liver fat</keyword>
	<keyword>Muscle fat</keyword>
	<keyword>Abdominal fat</keyword>
	<keyword>Cytokines</keyword>
</DOC>